News

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues.

VBI Vaccines has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s LPV™ Platform. VBI’s LPV Platform is a proprietary formulation and process that enables the development of vaccines and biologics with improved stability and preserved potency.

A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.

This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.

The healing powers of honey have been known for thousands of years.

Humboldt State’s cutting-edge program to prepare the next generation of stem cell and regenerative medicine professionals has received a major boost.

Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.

Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.

About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.

Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.